|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 174.10 USD | +0.93% |
|
-3.97% | +13.85% |
Company Valuation: Biogen Inc.
Data adjusted to current consolidation scope
| Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|---|---|---|---|
| Capitalization 1 | 37,679 | 35,242 | 39,877 | 37,495 | 22,283 | 25,541 | - | - |
| Change | - | -6.47% | 13.15% | -5.97% | -40.57% | 14.62% | - | - |
| Enterprise Value (EV) 1 | 41,723 | 37,820 | 40,560 | 43,384 | 26,204 | 27,496 | 24,236 | 21,746 |
| Change | - | -9.35% | 7.24% | 6.96% | -39.6% | 4.93% | -11.86% | -10.27% |
| P/E ratio | 9.87x | 23.1x | 13.3x | 32.5x | 13.7x | 16.2x | 14.1x | 12.4x |
| PBR | 3.7x | 3.26x | 3.02x | 2.53x | 1.33x | 1.38x | 1.25x | 1.14x |
| PEG | - | -0.4x | 0x | -0.5x | 0.3x | -4.29x | 1x | 0.9x |
| Capitalization / Revenue | 2.8x | 3.21x | 3.92x | 3.81x | 2.3x | 2.6x | 2.74x | 2.75x |
| EV / Revenue | 3.1x | 3.44x | 3.99x | 4.41x | 2.71x | 2.8x | 2.6x | 2.34x |
| EV / EBITDA | 5.56x | 9.13x | 11.2x | 14.3x | 7.1x | 8.54x | 7.4x | 6.97x |
| EV / EBIT | 6.1x | 10.3x | 13.1x | 17x | 8.69x | 9.75x | 8.52x | 7.58x |
| EV / FCF | 11x | 11.2x | 35.5x | 34.2x | 9.63x | 12.8x | 9.04x | 8.13x |
| FCF Yield | 9.12% | 8.94% | 2.82% | 2.93% | 10.4% | 7.8% | 11.1% | 12.3% |
| Dividend per Share 2 | - | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - | - |
| EPS 2 | 24.8 | 10.4 | 20.87 | 7.97 | 11.18 | 10.76 | 12.34 | 14.02 |
| Distribution rate | - | - | - | - | - | - | - | - |
| Net sales 1 | 13,445 | 10,982 | 10,173 | 9,836 | 9,676 | 9,816 | 9,327 | 9,282 |
| EBITDA 1 | 7,504 | 4,144 | 3,618 | 3,040 | 3,689 | 3,218 | 3,275 | 3,119 |
| EBIT 1 | 6,837 | 3,656 | 3,099 | 2,545 | 3,015 | 2,820 | 2,845 | 2,868 |
| Net income 1 | 4,001 | 1,556 | 3,047 | 1,161 | 1,632 | 1,537 | 1,819 | 2,015 |
| Net Debt 1 | 4,044 | 2,578 | 683 | 5,888 | 3,921 | 1,956 | -1,305 | -3,794 |
| Reference price 2 | 244.86 | 239.92 | 276.92 | 258.77 | 152.92 | 174.10 | 174.10 | 174.10 |
| Nbr of stocks (in thousands) | 153,882 | 146,893 | 144,001 | 144,898 | 145,719 | 146,702 | - | - |
| Announcement Date | 2/3/21 | 2/3/22 | 2/15/23 | 2/13/24 | 2/12/25 | - | - | - |
1USD in Million2USD
Estimates
P/E ratio, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
| 16.18x | 2.8x | 8.54x | -.--% | 25.54B | ||
| 18.14x | 4.9x | 12.92x | 0.5% | 76.06B | ||
| 23.31x | 4.23x | 12.29x | 2.53% | 58.92B | ||
| 50.21x | 13.28x | 28.8x | -.--% | 53.01B | ||
| 39.69x | 6.14x | 19.91x | 0.6% | 52.48B | ||
| 78.56x | 9.37x | 84.18x | -.--% | 18.76B | ||
| 15.46x | 2.96x | 9.4x | -.--% | 18.73B | ||
| 250.3x | 93.14x | 146.99x | - | 15.67B | ||
| -21.8x | 31.64x | -32.06x | -.--% | 14.48B | ||
| Average | 52.23x | 18.72x | 32.33x | 0.45% | 37.07B | |
| Weighted average by Cap. | 39.81x | 11.60x | 24.25x | 0.69% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Equities
- BIIB Stock
- Valuation Biogen Inc.
Select your edition
All financial news and data tailored to specific country editions
















